On Wednesday, Blend Labs Inc (BLND) stock saw a decline, ending the day at $4.36 which represents a decrease of $-0.19 or -4.18% from the prior close of $4.55. The stock opened at $4.59 and touched a ...
Hosted on MSN1d
Canaccord Genuity Downgrades Doximity (DOCS)Fintel reports that on November 13, 2024, Canaccord Genuity downgraded their outlook for Doximity (NYSE:DOCS) from Buy to ...
Fintel on MSN1d
Canaccord Genuity Upgrades Viant Technology (DSP)Fintel reports that on November 13, 2024, Canaccord Genuity upgraded their outlook for Viant Technology (NasdaqGS:DSP) from ...
ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness ...
Canaccord Genuity Group Inc. recorded strong growth in wealth-management and capital-markets divisions for its fiscal second ...
Canaccord Genuity Group (TSE:CF – Get Free Report) had its price target increased by investment analysts at Ventum Financial from C$10.25 to C$12.00 in a report issued on Monday,BayStreet.CA reports.
Firm-wide Revenue: $128 million for the quarter, up 27% year-over-year. Fiscal Year-to-Date Revenue: $857 million, up 26% ...
Stantec (TSE:STN – Get Free Report) (NYSE:STN) had its price target hoisted by stock analysts at Canaccord Genuity Group from ...
Analysts at Canaccord Genuity lowered their target price on shipbroking services business Braemar from 410.0p to 380.0p on ...
Good morning, ladies and gentlemen. Thank you for standing by. I'd like to welcome everyone to the Canaccord Genuity Group Inc. Fiscal 2025 Second Quarter Results Conference Call. All lines have been ...
About Elutia Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback